🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you for the invitation Amy H Attaway MD MS. It was an honor to speak to this amazing group of physician-scientists!

Excited for our protein risk score and mortality in individuals who smoke paper to come out: nature.com/articles/s4159… Fun collaboration and interesting findings with respect to respiratory vs cardiovascular mortality. Michael Cho Yohannes Tesfaigzi Ani Manichaikul Iain Konigsberg

Took a science break and saw ⁦KALEO⁩ crush it ⁦Roadrunner⁩. What a great night

Thanks Pradeep Natarajan

Great talk on COPD and SDOH in genetically resilient individuals CHEST 2024 meeting by @ajghosh Craig Hersh MD Michael Cho

Our Annals of the ATS paper is in press examining rheumatoid arthritis risk factors with ILA in MESA & COPDGene. atsjournals.org/doi/metrics/10…

Lung Tissue Multilayer Network Analysis Uncovers the Molecular Heterogeneity of Chronic Obstructive Pulmonary Disease American Thoracic Society (ATS) 🔗 tinyurl.com/5ct6a7rp

Great talk Divay Chandra

It’s really a privilege to mentor residents and fellows like Kevin Tong BU/BMC IM Residency who wrote this interesting review on PRISm with us. pubmed.ncbi.nlm.nih.gov/39569648/ Check put the Table 1 he made summarizing the literature. Very helpful!

Some very good news for people with asthma and COPD. The first new treatment for acute attacks in over 50 years—a monoclonal antibody vs interleukin-5 receptor-α—with efficacy in a randomized trial thelancet.com/journals/lanre… The Lancet Respiratory Medicine Sanjay Ramakrishnan Mona Bafadhel King's Faculty of Life Sciences & Medicine

I feel very grateful and lucky to be recognized with this Young Physician-Scientist Award. Many thanks to Michael Cho and Russ Bowler for the nomination as well as so many collaborators and mentors. Congrats to my colleagues too, jeong yun, nick bosch!

A chronic obstructive pulmonary disease (COPD) polygenic risk score enhances the identification of undiagnosed COPD beyond a conventional case-finding approach in the general population. ja.ma/3Cssm23

Happy #ManuscriptMonday! Check out this freshly published paper from Jingzhou Zhang and team (including Dr. Victor Ortega and senior author Matthew Moll, MD, MPH - hint for an upcoming CP Webinar 👀) bit.ly/40Q0hLq

Excellent course. Still remember taking it and was glad I did!

Thanks Helio for highlighting our work!

1/2 New pub in ATS Blue Journal We challenge the paradigm that all emphysema results from small airway disease. We show that most new emphysema arises from areas of high Mechanically Affected Lung (MAL) and in substantially higher proportion than areas of small airways disease.